
Characteristics of Interventional Study
No. | Author (yr) | Characteristics of participants | Study size | Intervention (n) | Control | Duration of treatment | Outcomes |
---|---|---|---|---|---|---|---|
1 | Lee JE 18) (2010) | Obese patient |
38 |
|
Placebo (18) |
4-5 weeks | BW, BMI, WC, WHR, BFM, FFM, PBF, BMR, TFA, VFA, SFA, VSR, TC, TG, HDL, LDL, glucose, CRP, leptin, adioponectin, KOQOL, SRI, KEAT-26, AST, ALT, γ-GT, BUN, Cr |
2 | Cho YJ 19) (2010) | Overweight child (Age 6-11) |
46 | I-razin (25) |
Placebo (21) |
8 weeks | BW, BMI, WC, visceral fat, blood glucose, TC, TG, AST, ALT |
3 | Kwon DH 20) (2011) | Obese female |
50 | Red Ginseng (26) |
Placebo (24) |
8 weeks | BW, BMI, WC, WHR, RMR, BF%, BFM, FI, BBT, KOQOL, FBST, TG, HDL, TC, sBP, dBP, PR, RR, AST, BUN, Cr, ALT |
4 | Park JH 23) (2012) | Obese patient |
114 | Boiogito (55) |
Placebo (56) |
8 weeks | BP, PR, BW, BMI, WC, RMR, ALT, AST, BUN, Cr, glucose, TC, HDL, TG, KOQOL |
5 | Lee CH 24) (2015) | NAFLD | 22 | Electroacupuncture (11) |
Control (11) | 8 weeks | AST, ALT, TG, TC, HDL, LDL, BST, γ-GTP, BW, BMI, FM, BFR, WHR, adverse events |
6 | Choi JB 29) (2017) | Obese patient |
36 |
|
Placebo (15) |
8 weeks | BW, BMI, BFM, BFR, WC, HC, WHR, TC, TG, LDL, HDL, ALT, AST, BUN, Cr |
7 | Jin YH 17) (2010) | Obese patient |
216 |
|
- | 15 days | t-BIL, ALP, AST, ALT |
8 | Ji JG 21) (2011) | Overweight female |
10 | Moving cupping therapy (10) |
- | 10 weeks | BW, BMI, PBF, WHR, WC, AC, TC, LDL, HDL, TG |
9 | Song EM 22) (2012) | Obese female |
25 | Far-infrared therapy (25) |
- | 6 weeks | BW, WC |
10 | Lee YH 25) (2015) | Obese patient |
254 | Herbal medicine (254) |
- | 1 month | BW, BMI, FM, skeletal mass, BFP |
11 | Shin SU 26) (2016) | Overweight patient |
33 | Modified fasting therapy (33) |
- | 15 days | BMI, BW, WC, BFM, MM, FFM, PBF, WHR, VFL, BMR, BP, CBC, WBC differential count, T-protein, albumin, globulin, AST, ALT, γ-GTP, ALP, T-bilirubiln, D-bilirubin, BUN, B/C ratio, FBS, TC, HDL, LDL, TG, Na+, K+, Ca+, hs-CRP, CRP, ESR, urinalysis, revised Chalder's fatigue scale, scores for ratingscale for subjective symptoms |
12 | Lee EJ 27) (2016) | Obese patient |
54 | Modified fasting therapy (33) | - | 5 weeks | BW, BMI, PBF, MM, WHR, VFL, BMR, adverse events |
13 | Shin WY 28) (2017) | Obese female |
344 | Herbal medicine (344) |
- | ≥15 days | BW, BF, muscular volume, BMI, BFR |
14 | Yoon NR 30) (2018) | Obese patient |
124 |
|
- | 10 weeks | WHO-UMC causality categories, LDS scale, adverse events according to SOC |
BMI: body mass index, BW: body weight, WC: waist circumference, WHR: waist-hip ratio, BFM: body fat mass, FFM: fat free mass, PBF: percent body fat, BMR: body metabolic rate, TFA: total fat area, VFA: visceral fat area, SFA: subcutaneous fat area, VSR: VFA/SFA ratio, TC: total cholesterol, TG: triglyceride, HDL: high-density lipoprotein, LDL: low-density lipoprotein, CRP: C-reactive protein, KOQOL: Korean version of obesity-related quality of life scale, SRI: stress response inventory, KEAT-26: Korean eating attitude test-26, AST: aspartate aminotransferase, ALT: alanine aminotransferase, γ-GT: γ-glutamic acid peptide transferase, BUN: blood urea nitrogen, Cr: creatine, RMR: resting metabolic rate, BF%: body fat %, FI: food intake, BBT: basal body temperature, FBST: fasting bllod sugar test, sBP: systolic blood pressure, dBP: diastolic blood pressure, PR: pulse rate, RR: RR interval, BP: blood pressure, NAFLD: non-alcoholic fatty liver disease, BST: blood sugar test, γ-GTP: γ-glutamyltranspeptidase, HC: hip circumference, t-BIL: total bilirubin, ALP: alkaline phosphatase, AC: arm circumference, FM: fat mass, MM: muscle mass, VFL: visceral fat level, CBC: complete blood count, WBC: white blood cell, T-protein: total protein, T-bilirubiln: total bilirubin, D-bilirubin: direct bilirubin, B/C ratio: bun/creatinine ratio, FBS: fasting blood sugar, hs-CRP: high sensitive C-reactive protein, ESR: erythrocyte sedimentation rate, BFR: body fat ratio, WHO-UMC Causality categories: World Health Organization-Uppsala Monitoring Centre Causality categories, SOC: system organ classes.